Pacific View Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Pacific View Asset Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$773K	Hold	112,887	–	–	3.71%	5
2019 Q2	$940K	Sell	112,887 -69,075	-38%	-$596K	1.02%	26
2019 Q1	$1.67M	Sell	181,962 -92,802	-34%	-$942K	1.73%	20
2018 Q4	$3.01M	Sell	274,764 -68,101	-20%	-$858K	3.54%	10
2018 Q3	$4.78M	Sell	342,865 -202,135	-37%	-$2.73M	3.81%	8
2018 Q2	$5.8M	Buy	545,000 +55,000	+11%	+$536K	4.59%	3
2018 Q1	$4.24M	Buy	490,000 +54,572	+13%	+$479K	3.19%	6
2017 Q4	$4.12M	Buy	+435,428	New	+$3.4M	2.73%	9

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Pacific View Asset Management's KIN Position: Q3 2019 in Review

Pacific View Asset Management held its Kindred Biosciences, Inc. (KIN) position steady in Q3 2019 at 112,887 shares worth $773K. The position accounts for 3.71% of the portfolio, ranked #5.

Pacific View Asset Management first reported a position in KIN in Q4 2017 and has held it in 8 quarters since. The position peaked at $5.8M in Q2 2018. 72 funds tracked by Wall St. Rank hold KIN as of Q3 2019.

Pacific View Asset Management held 112,887 shares of Kindred Biosciences, Inc. worth $773K as of Q3 2019.
Pacific View Asset Management left its Kindred Biosciences, Inc. share count unchanged in Q3 2019.
Kindred Biosciences, Inc. made up 3.71% of Pacific View Asset Management's portfolio in Q3 2019, its #5 holding.
Pacific View Asset Management first reported a position in Kindred Biosciences, Inc. in Q4 2017 and has held it in 8 quarters since.
Pacific View Asset Management's Kindred Biosciences, Inc. position peaked at $5.8M in Q2 2018.
72 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.